Literature DB >> 7237722

Effect of myocardial infarction on high-frequency QRS potentials.

A L Goldberger, V Bhargava, V Froelicher, J Covell.   

Abstract

Studies have shown that the number of high-frequency QRS notches increases after myocardial infarction (MI). To assess overall high-frequency (greater than 80 Hz) potentials more quantitatively, we adapted filtered and the root-mean-square (RMS) voltage of the residual (80-300 Hz) signal computed. High-frequency RMS values were significantly (p less than 0.01) greater in leads II, III and aVf in normal subjects (n = 12) than in patients with inferior infarction (n = 12). Similarly, high-frequency RMS values were higher (p less than 0.01) in leads V2 and V5 in normal subjects (n = 14) than in patients with prior anterior MI (n = 14). A reduction in high-frequency RMS values with inferior infarction was independently confirmed using Fourier analysis of the QRS in lead II. QRS notching in these subjects was also quantified by computing the number of baseline crossings of the first derivative (dV/dt). As predicted, notching was significantly greater (p less than 0.05) both with inferior MI (lead II) and anterior MI (lead V5). However, contrary to classic theory, the number of notches correlated negatively with direct measurements of high-frequency RMS voltage in lead II (r = -0.63) and lead V5 (r = -0.49). Positive correlations were obtained between high-frequency potentials and two new indexes that measure the amplitude of QRS dV/dt-peak-to-peak amplitude of dV/dt and RMS dV/dt. Using these indexes, absolute separation of inferior MI patients and normal subjects was obtained. We conclude that MI increases low-amplitude QRS notching but diminishes total high-frequency voltage, probably because of an overall decrease in electromotive potentials and slowing of ventricular conduction.

Entities:  

Mesh:

Year:  1981        PMID: 7237722     DOI: 10.1161/01.cir.64.1.34

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Fast and reliable QRS alignment technique for high-frequency analysis of signal-averaged ECG.

Authors:  O J Escalona; R H Mitchell; D E Balderson; D W Harron
Journal:  Med Biol Eng Comput       Date:  1993-07       Impact factor: 2.602

2.  On a mechanism of cardiac electrical stability. The fractal hypothesis.

Authors:  A L Goldberger; V Bhargava; B J West; A J Mandell
Journal:  Biophys J       Date:  1985-09       Impact factor: 4.033

3.  Atrial fibrillation after coronary artery bypass grafting. An increase in high-frequency atrial activity in patients with right coronary artery revascularization.

Authors:  Y Terada; T Mitsui; S Matsushita; O Shigeta; N Atsumi; T Jikuya; Y Sakakibara
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-01

4.  High-frequency QRS analysis in patients with acute myocardial infarction: a preliminary study.

Authors:  Guy Amit; Ori Galante; Linda R Davrath; Oded Luria; Shimon Abboud; Doron Zahger
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

5.  Fractals in physiology and medicine.

Authors:  A L Goldberger; B J West
Journal:  Yale J Biol Med       Date:  1987 Sep-Oct

6.  Ventricular dyssynchrony assessment using ultra-high frequency ECG technique.

Authors:  Pavel Jurak; Josef Halamek; Jaroslav Meluzin; Filip Plesinger; Tereza Postranecka; Jolana Lipoldova; Miroslav Novak; Vlastimil Vondra; Ivo Viscor; Ladislav Soukup; Petr Klimes; Petr Vesely; Josef Sumbera; Karel Zeman; Roshini S Asirvatham; Jason Tri; Samuel J Asirvatham; Pavel Leinveber
Journal:  J Interv Card Electrophysiol       Date:  2017-07-10       Impact factor: 1.900

7.  High-frequency QRS analysis to supplement ST evaluation in exercise stress electrocardiography: Incremental diagnostic accuracy and net reclassification.

Authors:  Pelbreton C Balfour; Jorge A Gonzalez; Peter W Shaw; Margarita P Caminero; Eric M Holland; Jack W Melson; Michael Sobczak; Valerie Izarnotegui; Denny D Watson; George A Beller; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2018-11-30       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.